Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Aug;73(4):312-7.
doi: 10.1016/j.diagmicrobio.2012.04.008. Epub 2012 May 29.

Specific elevation of DcR3 in sera of sepsis patients and its potential role as a clinically important biomarker of sepsis

Affiliations

Specific elevation of DcR3 in sera of sepsis patients and its potential role as a clinically important biomarker of sepsis

Sunghee Kim et al. Diagn Microbiol Infect Dis. 2012 Aug.

Abstract

Because of its potentially important role in the pathogenesis of sepsis, the expression of soluble decoy receptor 3 (DcR3) was investigated in sera of sepsis patients. The serum levels of DcR3 and its tumor necrosis factor-like ligand TL1A and homologous decoy receptor OPG were quantified by ELISA. The values of DcR3 to diagnose sepsis were analyzed by receiver-operating characteristic (ROC) curves. The results showed that DcR3 was significantly elevated in sepsis compared to systemic inflammatory response syndrome (SIRS), a condition similar to sepsis but resulting from noninfectious insults. DcR3 showed superior area under the ROC curve (AUC, 0.958) compared to poor AUCs of TL1A and OPG. At a cut-off of 3.24 ng/mL, DcR3 predicted sepsis from SIRS with 96% sensitivity and 82.6% specificity. DcR3 also predicted sepsis from cancer and inflammatory bowel disease with equally excellent values. Therefore, DcR3 serum level has the potential to serve as a reliable biomarker of sepsis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Prominent DcR3 increases in sera of sepsis patients. DcR3 concentration was quantified by ELISA. The mean values of normal, SIRS, sepsis, RCC, and CD were 0.43 ± 0.081 (n = 46), 2.06 ± 0.33 (n = 23), 10.46 ± 1.46 (n = 25), 1.09 ± 0.24 (n = 48), and 3.23 ± 1.75 (n = 30), respectively. P value (ANOVA test) for comparison of all 5 groups was < 0.0001. Protein concentrations are shown in logarithmic scale. The bars indicate median. SIRS = Systemic inflammatory response syndrome; RCC = renal cell cancer; CD = Crohn's disease.
Fig. 2
Fig. 2
Specific elevation of DcR3 serum level in sepsis. The concentrations of DcR3, TL1A, and OPG were quantified in sera of patients with sepsis or SIRS. Box and whiskers plots are presented to show median and interquartile (25th–75th) ranges. Protein concentrations are shown in logarithmic scale. P values (ANOVA test) for comparison among normal, sepsis, and SIRS were < 0.0001, 0.0017, and 0.5755 for DcR3, OPG, and TL1A, respectively. P values (Mann–Whitney test) between sepsis and SIRS were < 0.0001, 0.5096, 0.5214 for DcR3, OPG, and TL1A, respectively.
Fig. 3
Fig. 3
Comparison of receiver-operating characteristic (ROC) curves for DcR3, OPG, and TL1A in predicting sepsis from SIRS. Areas under the ROC curve (AUC) for DcR3, OPG, and TL1A were 0.958 (95% confidence interval [CI]: 0.857–0.995), 0.578 (95% CI: 0.425–0.720), and 0.528 (95% CI: 0.377–0.675), respectively. P values of DcR3 versus OPG and DcR3 versus TL1A were < 0.0001, while the P value between OPG and TL1A was 0.7280.

Similar articles

Cited by

References

    1. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864–874. - PubMed
    1. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303–1310. - PubMed
    1. Boomer J.S., To K., Chang K.C., Takasu O., Osborne D.F., Walton A.H. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA. 2011;306:2594–2605. - PMC - PubMed
    1. Calich V.L., Pina A., Felonato M., Bernardino S., Costa T.A., Loures F.V. Toll-like receptors and fungal infections: the role of TLR2, TLR4 and MyD88 in paracoccidioidomycosis. FEMS Immunol Med Microbiol. 2008;53:1–7. - PubMed
    1. Chang Y.C., Hsu T.L., Lin H.H., Chio C.C., Chiu A.W., Chen N.J. Modulation of macrophage differentiation and activation by decoy receptor 3. J Leukoc Biol. 2004;75:486–494. - PubMed

Publication types

Substances